General Information
Drug ID
DR00227
Drug Name
Rivaroxaban
Synonyms
XARELTO (TN)
Drug Type
Small molecular drug
Indication Prophylaxis of deep vein thrombosis [ICD11: BD71] Approved [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=9875401"></iframe>
3D MOL 2D MOL
Formula
C19H18ClN3O5S
Canonical SMILES
C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl
InChI
InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1
InChIKey
KGFYHTZWPPHNLQ-AWEZNQCLSA-N
CAS Number
CAS 366789-02-8
Pharmaceutical Properties Molecular Weight 435.879 Topological Polar Surface Area 116
Heavy Atom Count 29 Rotatable Bond Count 5
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 6
PubChem CID
9875401
PubChem SID
103469795 , 109693118 , 126659499 , 126666963 , 134342998 , 134358083 , 135213418 , 135684125 , 136375511 , 136920411 , 137128738 , 139479843 , 14856850 , 152258851 , 152344334 , 15279667 , 160645892 , 160647701 , 160969514 , 162172236 , 164045359 , 164194090 , 164824489 , 165245531 , 170498903 , 171578894 , 172091286 , 174477515 , 175266472 , 175427064 , 175610897 , 177748765 , 178103004 , 180189087 , 185985285 , 198991713 , 22395270 , 24164597 , 45622373 , 46513422 , 51091428 , 52936629 , 56373953 , 57373622 , 71825413 , 87225360 , 87557471 , 91615930 , 93580340 , 99444948
ChEBI ID
ChEBI:68579
TTD Drug ID
D0KG3R
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 Rivaroxaban was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Absence of both MDR1 (ABCB1) and breast cancer resistance protein (ABCG2) transporters significantly alters rivaroxaban disposition and central nervous system entry. Basic Clin Pharmacol Toxicol. 2013 Mar;112(3):164-70.
3 Downregulation of ABCB1 gene in patients with total hip or knee arthroplasty influences pharmacokinetics of rivaroxaban: a population pharmacokinetic-pharmacodynamic study. Eur J Clin Pharmacol. 2019 Feb 6.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.